About Author : Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With experience in technical and niche writing, he was encouraged to opt for a career in content writing and now pens down articles pertaining to market research, industry news and business trends.



Contribution by Pankaj Singh

Hummingbird Bio secures $19M to expand antibody therapeutics portfolio

Hummingbird Bioscience, an advanced biotherapeutics company, recently announced it has raised USD 19 million in a Series B funding round. Apparently, the financing round was co-led by GNTech Venture Capital and Mirae Asset Venture Investment. Source...

Read More
Acadia announces positive results of Phase 3 trial to treat psychosis

Acadia Pharmaceuticals, a renowned US-based biopharmaceutical company dedicated to the development of treatments for central nervous system disorders, reportedly announced positive outcomes from its Phase 3 HARMONY study of pimavanserin. The company...

Read More
Senseonics’ Eversense® obtains non-adjunctive labeling claim in U.S.

Senseonics Holdings, Inc., a US-based medical device startup company recently announced that users of its Eversense CGM (continuous glucose monitoring) system can now use the new Eversense CGM mobile application for dosing insulin based on the r...

Read More
Astellas Pharma inks a $3 Bln deal to acquire Audentes Therapeutics

Japanese pharmaceutical company, Astellas Pharma Inc. has reportedly entered into a definitive agreement to acquire biotech firm Audentes Therapeutics, Inc. at a price of US$60.00 per share in cash, representing equity value of around US$3 billion. ...

Read More
FDA accepts NDA for Pemigatinib, announces Innovent Biologics

  Pemigatinib has been granted priority review by the FDA The FGFR1/2/3 inhibitor is a therapy for patients with cholangiocarcinoma The clinical stage product candidate has been developed by Incyte Corporation Despite a plethora of advanc...

Read More
Bio-Path Holdings finalizes safety testing in Phase 2 trial targeting AML

Bio-Path Holdings Inc., a biotechnology company developing novel therapeutics, has reportedly announced the successful completion of safety testing of prexigebersen combined with decitabine in patients with AML (acute myeloid leukemia) and MDS ( myel...

Read More
Intuitive’s E-100 generator and SynchroSeal gets the FDA clearance

Intuitive, a US-based developer, manufacturer, and marketer of the robotic products designed to improve clinical results of patients through robot-assisted surgeries, reportedly announced that two of its technologies for its da Vinci surgical systems...

Read More
Ferring and Blackstone jointly invest in a new bladder cancer therapy

Private investment firm, Blackstone Life Sciences and Ferring Pharmaceuticals recently announced joint investment of more than USD 570 million in a novel investigational  gene therapy, rAd-IFN/Syn3 (nadofaragene firadenovec). The therapy is bein...

Read More
AVITA Medical & Gates Center unite to explore spray-on skin treatment

AVITA Medical and Gates Center for Regenerative Medicine have reportedly inked a Sponsored Research Agreement or SRA to develop treatments for genetic skin conditions. The firms will conduct preclinical trials to develop spray-on skin treatments usin...

Read More
Early data from first human CRISPR trials reveals promising results

Vertex Pharmaceuticals and CRISPR Therapeutics have recently revealed early data from their joint trials to test CRISPR treatment in humans. The data was obtained from two patients suffering from serious blood disorders. Trial data indicates towards ...

Read More
Novartis’ trial of Entresto reveals potential beyond HFrEF treatment

Swiss pharma-company Novartis has reportedly revealed subgroup results from its global PARAGON-HF Phase III study. The trial involved a study of patients suffering from HFpEF (heart failure with preserved ejection fraction) or diastolic heart failure...

Read More
Nike to halt direct sale of its shoes and clothes through Amazon

In efforts to retain their relevance in the continuously evolving world of ecommerce, companies are losing the personal touch they once had with their customers. Lately however, prominent brands that have a well-established reputation among consumers...

Read More
Stanford medicine releases its research on Apple Heart watches

The study comprised enrollment of over 400,000 people, making it one of the biggest research efforts.   It also saw approximately 2,000 of people receiving notification of irregular pulse. California-based Stanford Medicine recently came o...

Read More
Yahoo Japan explores plans for a merger with Navers Line app

Yahoo! Japan Corp., a Japanese internet firm, has recently cleared the fog on its merger with trending messaging app Line. According to reports, the merger would see the formation of a new internet group that would cover retail, finance and various o...

Read More
Skyroam Solis X launched online for purchase or rental options

In this era of smart technologies and digitalization, the need for high speed internet connectivity have been doing rounds globally. To suffice these requirements, Skyroam Hotspot has taken a step forward to equip its online customers with WiFi smart...

Read More
Spell & The Gypsy Collective rolled out on Workarea Commerce Cloud

Workarea Commerce, a renowned commerce platform for new merchants across various sectors, and Syatt Media, a Canada based e-commerce agency with deep platform and industry expertise, announced that Spell & The Gypsy Collective, a rapidly emerging...

Read More
WeChat Pay & Alipay allow overseas users to use international cards

On the foundation of the popular digital payment services, China is moving towards a cashless economy. In a bid to offer ease to international users, Chinese mobile payment giants WeChat Pay and Alipay have recently started allowing foreigners to lin...

Read More
Seller Labs acquires eCommerce service & software provider X-Cart

Since the past five years, Seller Labs’ team has observed diverse needs by brands and sellers. From beginning as an Amazon seller to developing software to decipher encountered issues, the company has grown in leaps and bounds which has enabled...

Read More
Knight & TherapeuticsMD amid filing a NDS for Joyesta™ in Canada

Knight Therapeutics Inc., a pharmaceutical company based in Canada, had last year entered a licensing agreement with drug manufacturer TherapeuticsMD, Inc. to gain sale rights for TX-004HR and TX-001HR in Israel and Canada. However, the two firm...

Read More
Themis Bioscience, CEPI initiate Phase 1 study for Lassa Fever vaccine

Lassa fever is a severe viral hemorrhagic illness which usually occurs due to human exposure to infected food or household items that are contaminated with feces or urine of Lasa virus infected Mastomys rats. This condition can mainly be seen in area...

Read More
Mirati Therapeutics reveals Phase ½ results of KRAS inhibitor therapy

Mirati Therapeutics, an oncology company that engages in the development of targeted therapies, recently released its clinical trial results for MRTX849. Reportedly, MRTX849 is a KRAS G12C inhibitor and the data from Phase ½ results were prese...

Read More
Best Buy to offer free next-day delivery feature on various products

Online retailers are always launching new and attractive deals during the holiday season, as it grosses the highest sale time for the year. Several retailer rollout out attractive offers, such as discounts or complimentary gifts to boost sales. ...

Read More
Nature Tech Corp partners with Aldevron for gene therapy manufacturing

The global cell and gene therapy sector is expected to witness a thriving period of growth over the forthcoming years. In fact, owing to the favorable growth conditions across the industry, numerous biotechnology and pharmaceutical firms in the field...

Read More
Genentech IMbrave150 study meets coprimary endpoints for HCC treatment

With growing occurrence of liver cancer cases across the globe, the need to find a solution to the ailment is rising steadily among global biotechnology and pharmaceutical firms. Various clinical trials and studies are increasingly being conducted to...

Read More
Vertex announces reimbursement of ORKAMBI and SYMDEKO in Australia

Vertex Pharmaceuticals Inc. is a global biopharmaceutical company that is relentless in striving for medical excellence while developing transformative therapies for life-threatening and serious diseases, such as cystic fibrosis. It has made a name f...

Read More
Centene, RxAdvance and Walgreens unveil new pharmacy management model

The cloud adoption trend is increasingly picking up momentum across a plethora of industry disciplines. Among these, the healthcare and pharmaceutical sector is emerging as a prominent cloud subscriber globally. Numerous industry players, including i...

Read More
Exicure reveals positive data from XCUR17 clinical trial for Psoriasis

Clinical trials play a vital role in developing new treatments that could immensely improve a person’s living. Today, researchers and pharmaceutical company are working hard for making breakthroughs in psoriasis treatments. Exicure Inc. is one...

Read More
Principia Biopharma reveals data from Phase 1/2 trial targeting ITP

Immune thrombocytopenia (ITP) is a type of blood abnormality that creates a shortage of blood cell fragments known as platelets required for normal blood clotting. While children with ITP get cured without treatment, adults on the other hand are...

Read More
Indian social commerce startup Mall91 raises $7.5M in Series A round

Mall91 reportedly plans on using the acquired funds for product development, boosting hiring and driving supply chain efforts, and realizing its global expansion ambitions. The startup, which currently operates in over 2000 cities in India, manag...

Read More
Asset manager Investcorp leads Bewakoof’s $11.2Mn funding round

India’s online fashion and lifestyle industry has seen tremendous growth in the past few years. Since being introduced, people are increasingly making purchases on such platforms, which is in turn opening new opportunities for fashion businesse...

Read More
Incyte unveils positive results from Phase 2 ruxolitinib cream study

Vitiligo is a prominent skin diseases prevalent across the world that causes skin color loss. The disease is increasingly being taken as a serious issue by various pharmaceutical firms across the globe, who are continuously working towards finding a ...

Read More
ProQR reveals positive results from Phase 1/2 trial of Sepofarsen

Leber congenital amaurosis (LCA) is a very rare eye condition that can be seen in newborn babies. Currently, the disease doesn’t have a permanent therapy, however, many pharma companies are now making some advancements to treat this diseas...

Read More
Bavarian Nordic begins Phase 1 clinical trial of MVA-BN® WEV vaccine

The trial will reportedly examine the safety, tolerability and immunogenicity of MVA-BN WEV The U.S. is currently facing the worst outbreak of the Eastern equine encephalitis virus (EEEV). Over 30 cases were reported in 2019, which included 9 fatal...

Read More
Illumina inks a long-term NGS deal with Dutch company Qiagen

The pharmaceutical industry is responsible for treating some of the most critical health issues. The sector produces, develops and markets drugs that could be beneficial to people on a larger scale. However, with growing competition in this prof...

Read More
HMS invests $7.5Mn in digital medication management firm MedAdvisor

Medication adherence or taking medications correctly and on time is one of the most important parts of any treatment. This also includes refilling prescriptions, making medication management a vital part of the pharmaceutical industry. In fact, its i...

Read More
Graybug Vision commences Phase 2b Clinical study to target wet AMD

Macular degeneration is the leading cause of irreversible, serious vision loss that occurs when a section of the retina known as the macula is damaged. It is often observed that Age-Related Macular Degeneration (AMD) is commonly o...

Read More
Merck reveals positive results from KEYTRUDA® Plus Phase 3 trial

Breast cancer is initiated when genes regulating cell growth mutate. These mutations allows the cells to divide and multiply rampantly and are formed in the ducts or lobules of the breast. Several pharmaceutical firms are developing novel treatments ...

Read More
Forever 21 files for Chapter 11 bankruptcy, plans to shut 178 stores

With the growing popularities of different types of clothing trends like hoodies, denim and T-shirts, clothing companies have to stay up to date on the latest styles, in order to be in the game. However, while concentrating on this aspect o...

Read More
Treos Bio updates results of phase 1/2 trial of its cancer vaccine

Vaccine-specific T cell responses were initially anticipated by PEPI test (via the complete HLA genotype of patient). Treos Bio Ltd. has reportedly updated positive outcomes on the second segment of phase 1/2 trial (OBERTO) along with PolyPEPI1018 ...

Read More
Marshalls finally marks its online presence with its new online store

Online retail and fashion stores have shown an exponential amount of growth in the past few years. Online sites eliminate the need for a brick and motor store, saving a huge amount of money which companies can redirect towards their marketing efforts...

Read More
Exact Sciences Cologuard® test gets label expansion approval from FDA

Colorectal cancer cases are increasingly growing across the world, however it is one of those cancers which can be treated if diagnosed at early stages. Various pharmaceutical and medical firms in the world are continuously working to find effective ...

Read More
XORTX reveals positive results for Phase 2 trial of TMX-049

Type 2 diabetes is a prevailing disease in which cells become unresponsive to insulin while gradually increasing blood sugar. With growing cases of Type 2 diabetes worldwide, pharmaceutical companies are now focusing on developing new drugs by means ...

Read More
Poxel releases detailed Imeglimin Phase 3 results from TIMES 1 program

Type 2 diabetes is a prevailing disease in which cells become unresponsive to insulin while gradually increasing blood sugar. With growing cases of Type 2 diabetes worldwide, pharmaceutical companies are now focusing on developing new drugs by means ...

Read More
Poxel commences its Phase 1b trial for NASH drug candidate, PXL065

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by the buildup of fat in the liver mostly with people who drink little or no alcohol. With growing cases of NASH prevailing worldwide, pharmaceutical companies are now focusing on devel...

Read More
Emergency Care Partners finalizes its merger with Chicago’s IEMS

With rising cases of roadside accidents worldwide, the need for emergency medical facilities have increased considerably in recent years. These facilities offer immediate assistance without any appointments, which makes them the go-to place for treat...

Read More
Flipkart extents delivery reach by 80% to cover more pincodes in India

The e-commerce site has managed to grow its reach to an estimate of 19,200 PIN codes from its prior 10,660 last year for the delivery of huge appliances.   The company has also raised its delivery capacity by 14 times in 2019. Flipkart, a ...

Read More
Zelegent expands to OSA therapeutics with MISH platform acquisition

MISH Technology stands for Minimally Invasive Suspension of the Hyoid and is a novel pre-clinical product line meant to treat obstructive sleep apnea (OSA). MISH is relatively less invasive when compared with presently used hyoid suspension produc...

Read More
Walmart to roll out Delivery Unlimited grocery service across U.S.

Walmart, the retail giant, recently announced that it is rolling out a new Delivery Unlimited grocery service in 1,400 Walmart stores across U.S. Reportedly, the subscription membership will charge an annual fee of USD $98 for subscribers to access u...

Read More
Amazon gears up for Diwali sale, expands next-day delivery service

The firm has increased its overall reach for large appliances to 14,000 pin codes and next-day delivery facilities to over 650 cities. Amazon.in, the Indian division of the e-commerce giant Amazon.com, Inc., has reportedly expanded its delivery capa...

Read More
4BIO Capital intends to take gene and cell therapies mainstream

The venture capitalist firm has secured an investment of $50 million and is expecting to gather an investment of up to $150 million till 2020. 4BIO Capital, a London-based firm investing in Public Equities in Life Sciences and Venture Capital, has m...

Read More
Lung Ambition Alliance reveals plans to double lung cancer survival

New program will be launched to help local initiatives run by patient organizations that contain the capability to further transform patient care.   The Lung Ambition Alliance has built an interactive booth where applicants will understand i...

Read More
SunGen Pharma and Elite Pharmaceuticals file an ANDA with the FDA

This is the second ANDA filed by both the companies, giving Elite Pharmaceutical the exclusive right to retail the drug. Elite Pharmaceuticals, Inc. a pharmaceutical company that creates niche generic products and abuse-deterrent opioids, recently a...

Read More
Ribon Therapeutics doses first patient in RBN-2397 Phase 1 trial

The Phase 1 clinical trial assessing RBN-2397 will be the first clinical evaluation of monoPARP Inhibitor.   RBN-2397 is the company’s PARP7 inhibitor and is capable of potently inhibiting cancer cell proliferation. Ribon Therapeutic...

Read More
Vertex acquires Semma Therapeutics for $950M to develop diabetes cure

The acquisition for $950 million has been an all-cash deal.   The strategic acquisition is expected to align itself perfectly with Vertex’s aim to create revolutionary medicines. Vertex Pharmaceuticals, a biopharmaceutical company ba...

Read More
Inotrem nangibotide program gets Fast Track designation from the FDA

The company’s therapeutic solution is capable of being the first septic shock treatment which is mechanism-based.   Inotrem will start its planned multinational multicentric Phase IIb trial in patients of septic shock later in 2019. ...

Read More
Immunicum AB reveals positive Phase II MERECA clinical trial data

Satisfactory safety profile and the positive number of complete responses by the trials firmly justify the prolonged clinical advancement of ilixadencel as an immune primer in solid tumors. Immunicum AB (publ), a Swedish biopharmaceutical company, h...

Read More
Hudsons Bay announces selling Lord & Taylor to Le Tote for USD 100 mn

The business retail group is claimed to be paid CAD 99.5 million cash once the deal concludes and a confirmatory note of CAD 33.2 million cash after 2 years. The acquisition will allow Le Tote to operate Lord & Taylor’s 38 stores along w...

Read More
Regenxbio to present interim update of RGX-314 Phase I/IIA trial

Dr. Jeffery Heier, the primary investigator of the trial, will present the data during the Retina Subspecialty day program held at AAO (American Academy of Ophthalmology) 2019 annual meeting, CA   The biotechnology firm is also planning to i...

Read More
Enrollment concluded early in PCS-499 clinical trial for NL treatment

Clinical stage biopharmaceutical firm Processa Pharmaceuticals Inc today announced the last patient to be enrolled in the Necrobiosis Lipoidica (NL) clinical study for PCS-499. The conclusion of enrollment signifies an important milestone in the dev...

Read More
Lupins Pharma Dynamics signs distribution agreement with Creso Pharma

The deal gives Lupin access to Creso’s cannaQIX product range, which are nutraceuticals based on cannabidiol hemp oil, utilized for reducing stress and help with nervous and mental functions.   Creso granted Pharma Dynamics sole distri...

Read More
Disney partners with Target to open new retail stores in the U.S.

The tie-up would also witness Target opening a small retail store near the Walt Disney World Resort by 2021. Target Corp., one of the largest retailer in the U.S., has recently announced plans to open dozens of permanent Disney stores wit...

Read More
Altaire’s veterinary ophthalmic products recalled due to QA concerns

Altaire Pharmaceuticals recalls specific product/lots of ophthalmic drugs created for Dechra Veterinary Products, due to sterility concerns.   No adverse effects have been reported yet.   The recall has been carried out in compliance ...

Read More
Mundipharma submits license extension for Invokana & Vokanamet to EMA

CREDENCE renal outcome study, that was stopped early because of positive efficacy findings, laid the foundation for submission of license extension.   Invokana® will be the first treatment in approximately 20 years indicated towards dec...

Read More
Outlook Therapeutics finishes patient registration for NORSE 1 trial

NORSE 1 has registered a sum of 61 patients from nine different sites in Australia.   This study is first of the two current, well controlled and adequate Phase 3 clinical trials examining ONS-5010 for wet AMD. Outlook Therapeutics Inc., a...

Read More
Biogen & Invitae introduce SMA STAT test for faster genetic testing

Global biotechnology expert Biogen Inc. and advanced genetics leader Invitae Corporation have reportedly announced their new rapid-turnaround test for genetic testing in the diagnosis for SMA (spinal muscular atrophy). The SMA STAT test is a part of...

Read More
Target launches flagship food label with more than 2000 products

US based retailer Target has reportedly announced the launch of its new private grocery brand, Good & Gather. Starting next month, Target stores across the United States will stock the first 650 Good & Gather products which will include item...

Read More
Lidl orders suppliers to pay duties on goods crossing Brexit borders

The company has asked the British suppliers to pay any import tariffs levied on goods crossing borders after Brexit. The current company contract comprises a DDP clause. Tariffs on food and milk are expected to be high. Lidl’s Irish busin...

Read More
FDA approves Rozlytrek™ for cancer patients with ROS1-positive & NTRK

FDA approves Rozlytrek™ for cancer patients with ROS1-positive & NTRK Rozlytrek™ will be Roche’s first FDA approved medicine that targets genetically mutilated cancer as well as both ROS1 and NTRK fusions. Roche Holding AG, a...

Read More
Bio-Thera Solutions commences Phase 1 study for Simponi® biosimilar

Bio-Thera Solutions, a China based pharmaceutical company, has reportedly announced the start of dosing of its first batch of healthy volunteers in order to compare the safety and pharmacokinetics of BAT2506, proposed as a biosimilar of Simponi (goli...

Read More
Rapid Nutrition ties up with Mr. Vitamins for competitive portfolio

The company has established a partnership with Australia’s largest natural health retailer to expand its distribution network. United Kingdom based Rapid Nutrition PLC has reportedly announced to have signed a partnership agreement with Austra...

Read More
Mevion & C-RAD integrate for better treatment in proton therapy

C-RAD to offer a specific version of Catalyst System named Catalyst PT in proton therapy. Catalyst PT would be especially used for thoracic tumor indications. Mevion Medical Systems® and C-RAD reportedly announced the combination of the MEVI...

Read More
Amazon plans to open a brick-and-mortar liquor store in San Francisco

The company is looking to launch a liquor shop in San Francisco for various alcoholic beverages.   Application for a liquor license and approval to open the shop in the city have been forwarded. The e-commerce giant Amazon Incorporation ha...

Read More
Experian takes over MyHealthDirect for patient engagement and access

MyHealthDirect’s easy-to-understand technology guides its patients to profound and right care. Acquisition of MyHealthDirect would strengthen Experian’s status as a foremost supplier of solutions which simplify healthcare’s admin...

Read More
Astrazenca reveals positive results from Phase III trial of Lynparza

Lynparza is a PARP inhibitor with promising Phase III results in ovarian breast pancreatic and prostate cancers. AstraZeneca plc a biopharmaceutical company and MSD Inc. (also known as Merck & Co. Inc. inside Canada and the U.S.) have recently a...

Read More
Moderna doses first patients across four new Phase I clinical studies

Moderna, a biotech company that focuses on discovery and development of drugs and is based in Cambridge, Massachusetts, announced recently that it has initiated four new Phase I clinical trials, two of which are related to infectious diseases and two...

Read More